Abstract:Background & Aims: Non-alcoholic steatohepatitis (NASH) is associated with the dysregulation of lipid metabolism and hepatic inflammation. The causal mechanism underlying NASH is not fully elucidated. This study investigated the role of beta-Arrestin1 (ARRB1) in the progression of NASH. Methods: Liver tissue from patients with NASH and controls were obtained to evaluate ARRB1 expression. NASH models were established in Arrb1-knockout and wild-type mice fed either a high-fat diet (HFD) for 26 weeks or a methionine/choline-deficient (MCD) diet for 6 weeks. Results: ARRB1 expression was reduced in liver samples from patients with NASH. Reduced Arrb1 levels were also detected in murine NASH models. Arrb1 deficiency accelerated steatohepatitis development in HFD-/MCD-fed mice (accompanied by the upregulation of lipogenic genes and downregulation of beta-oxidative genes). Intriguingly, ARRB1 was found to interact with growth differentiation factor 15 (GDF15) and facilitated the transportation of GDF15 precursor (pro-GDF15) to the Golgi apparatus for cleavage and maturation. Treatment with recombinant GDF15 ablated the lipid accumulation in the presence of Arrb1 deletion both in vitro and in vivo. Re-expression of Arrb1 in the NASH models ameliorated the liver disease, and this effect was greater in the presence of pro-GDF15 overexpression. By contrast, the effect of pro-GDF15 overexpression alone was impaired in Arrb1-deficient mice. In addition, the severity of liver disease in patients with NASH was negatively correlated with ARRB1 expression. Conclusion: ARRB1 acts as a vital regulator in the development of NASH by facilitating the translocation of GDF15 to the Golgi apparatus and its subsequent maturation. Thus, ARRB1 is a potential therapeutic target for the treatment of NASH. Lay summary: Non-alcoholic steatohepatitis (NASH) is associated with the progressive dysfunction of lipid metabolism and a consequent inflammatory response. Decreased ARRB1 is observed in patients with NASH and murine NASH models. Re-expression of Arrb1 in the murine NASH model ameliorated liver disease, an effect which was more pronounced in the presence of pro-GDF15 overexpression, highlighting a promising strategy for NASH therapy. (c) 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism Via the Akt-Dependent Pathway

Β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein.

Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver

Thyroid-stimulating Hormone Regulates Hepatic Bile Acid Homeostasis Via SREBP-2/HNF-4α/CYP7A1 Axis

Β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (Tlr4)-Triggered Inflammatory Signaling Via Targeting P38 MAPK and Interleukin 10.

Thyroid hormone receptor beta (THRB) dependent regulation of diurnal hepatic lipid metabolism in adult male mice

Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis.

Arrb2 Causes Hepatic Lipid Metabolism Disorder Via AMPK Pathway Based on Metabolomics in Alcoholic Fatty Liver

ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6-mediated Lysine 6-linked polyubiquitination of ASK1 in hepatocytes

Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway

Thyroid-Stimulating Hormone Increases HNF-4α Phosphorylation via cAMP/PKA Pathway in the Liver

Β-Arrestin-2 Attenuates Hepatic Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling

ARRB1 Inhibits Non-Alcoholic Steatohepatitis Progression by Promoting GDF15 Maturation.

Tributyltin Chloride Induces Abca1 Expression and Apolipoprotein A-I-Mediated Cellular Cholesterol Efflux by Activating Lxralpha/Rxr

Β-Arrestin-1 Protein Represses Adipogenesis and Inflammatory Responses Through Its Interaction with Peroxisome Proliferator-activated Receptor-γ (Pparγ)

A novel role for thyroid-stimulating hormone: Up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protei

Thyroid-Stimulating Hormone Increases Hnf-4 Alpha Phosphorylation Via Camp/Pka Pathway In The Liver

Β-Arrestin2 Recruitment by Β-Adrenergic Receptor Agonists and Antagonists

A Novel Role for Crtc2 in Hepatic Cholesterol Synthesis Through Srebp-2

Two uniquely arranged thyroid hormone response elements in the far upstream 5′ flanking region confer direct thyroid hormone regulation to the murine cholesterol 7α hydroxylase gene

β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling